Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity

Journal of Hypertension

Volumn 23, Issue 8, 2005, Pages 1477-1484

  So, Albertina ^a   Duffy, David L ^b   Gordon, Richard D ^a   Jeske, Yvette W A ^a   Lin Su, Karen ^c   New, Maria I ^c   Stowasser, Michael ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Familial; Genetic; Hypertension; Linkage; Primary aldosteronism

Indexed keywords

ALDOSTERONE; FLUDROCORTISONE; RENIN;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; AUSTRALIA; BLOOD PRESSURE; CHROMOSOME 7P; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FAMILIAL DISEASE; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC MARKER; GENETIC RECOMBINATION; GENOTYPE; HAPLOTYPE; HUMAN; MICROSATELLITE MARKER; PHENOTYPE; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCORING SYSTEM; SOUTH AMERICA;

EID: 23344432663     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000174299.66369.26     Document Type: Article

References (33)

1. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994; 21:315-318.
2. Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 2000; 14:311-315.
3. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000; 85:2854-2859.
4. Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L, et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000; 85:1863-1867.
5. Hiramatsu K, Yamada T, Yukimura Y, Kominya I, Ichikawa K, Ishihara M, et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 1981; 141:1589-1593.
6. Gordon RD, Klemm SA, Tunny TJ, Stowasser M. Primary aldosteronism: hypertension with a genetic basis. Lancet 1992; 340:159-161.
7. Gordon RD, Stowasser M, Rutherford JC. Primary aldosteronism: are we diagnosing and operating on too few patients? World J Surg 2001; 25:941-947.
8. Sutherland DJA, Ruse JL, Laidlaw JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 1966; 95:1109-1119.
9. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, et al. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 335:262-265.
10. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Finn WL, Krek AL. Clinical and pathological diversity of primary aldosteronism including a new familial variety. Clin Exper Pharmacol Physiol 1991; 18:283-286.
11. Stowasser M, Gordon RD, Tunny TJ, Klemm SA, Finn WL, Krek AL. Primary aldosteronism: implications of a new familial variety. J Hypertens 1991; 9 (suppl 6):S264-S265.
12. Gordon RD, Stowasser M. Familial forms broaden horizons in primary aldosteronism. Trends Endocrinol Metab 1998; 9:220-227.
13. Stowasser M, Gordon RD. Primary aldosteronism; learning from the study of familial varieties. J Hypertens 2000; 18:1165-1176.
14. Stowasser M, Gordon RD. Familial hyperaldosteronism. J Steroid Biochem Mol Biol 2001; 78:215-229.
15. Torpy DJ, Gordon RD, Lin J-P, Huggard PR, Taymans SE, Stowasser M, et al. Familial hyperaldosteronism type-II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. J Clin Endocrinol Metab 1998; 83:3214-3218.
16. Torpy DJ, Taymans S, Pack S, Pak E, Stowasser M, Huggard P, et al. Reassignment of the CYP11B2 locus to human chromosome 8q24.3 and exclusion of linkage of the CYP11B2 gene to familial hyperaldosteronism type II (FH-II). J Clin Endocrino Metab 1998; 83:1046.
17. Lafferty AR, Torpy DJ, Stowasser M, Taymans SE, Lin JP, Huggard P, et al. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7(7p22). J Med Genet 2000; 37:831-835.
18. Gordon RD, Stowasser M, Klemm SA, Tunny TJ. Primary aldosteronism and other forms of mineralocorticoid hypertension. In: Swales JD (editor): Textbook of hypertension. Oxford: Blackwell Scientific; 1994, pp. 865-892.
19. Jonsson JR, Klemm SA, Tunny TJ, Stowasser M, Gordon RD. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem Biophys Res Comm 1995; 207:565-571.
20. Rychlik W, Rhoads RE. A computer program for choosing optimal oligonucleotides for filter hybridization, sequencing and in vitro amplification of DNA. Nucl Acids Res 1989; 17:8543-8551.
21. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11:241-247.
22. Warnock D. Liddle syndrome: genetics and mechanisms of Na+ channel defects. Am J Med Sci 2001; 322:302-307.
23. Achard JM, Disse-Nicodeme S, Fiquet-Kempf B, Jeunemaitre X. Phenotypic and genetic heterogeneity of familial hyperkalaemic hypertension (Gordon syndrome). Clin Exper Pharmacol Physiol 2001; 28:1048-1052.
24. Carmeci C, Thompson DA, Ring HZ, Francke U, Weigel RJ. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 1997; 45:607-617.
25. Tsukasaki K, Miller CW, Greenspun E, Eshaghian S, Kawabata H, Fujimoto T, et al. Mutations in the mitotic check point gene, MAD1L1, in human cancers. Oncogene 2001; 20:3301-3305.
26. Igarashi K, Itoh K, Motohashi H, Hayashi N, Matuzaki Y, Nakauchi H, et al. Activity and expression of murine small Maf family protein MafK. J Biol Chem 1995; 270:7615-7624.
27. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, et al. Mutations of the gene encoding the protein kinase A type 1-α regulatory subunit in patients with the Carney complex. Nat Genet 2000; 26:89-92.
28. Elphinstone MS, Gordon RD, So A, Jeske Y, Stratakis CA, Stowasser M. Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: no evidence for mutations in familial hyperaldosteronism type II in a large affected kindred. Clin Endocrinol 2004; 61:716-723.
29. Fallo F, Pilon C, Barzon L, Pistorello M, Sonino N, Veglio F, et al. Retention of heterozygosity at chromosome 7p22 and 11q13 in aldosterone- producing tumours of patients with familial hyperaldosteronism not remediable by glucocorticoids. J Hum Hypertens 2004; 18:829-830.
30. Hamilton SR, Liu B, Parson RE, Papadopoulos N, Jen J, Powell SM, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995; 332:839-847.
31. Skapek SX, Jansen D, Wei TF, McDermott T, Huang W, Olson EN, et al. Cloning and characterization of a novel Kruppel-associated box family transcriptional repressor that interacts with the retinoblastoma gene product, RB. J Biol Chem 2000; 275:7212-7223.
32. Chan AM, Fleming TP, McGovern ES, Chedid M, Miki T, Aaronson SA. Expression cDNA cloning of a transforming gene encoding the wild-type G-alpha-12 gene product. Mol Cell Biol 1993; 13:762-768.
33. Irani K, Xia Y, Zweier JL, Sollott S, Der CJ, Fearon ER, et al. Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science 1997; 275:1649-1652.